Appendix Table 2.

Sensitivity Analysis Focusing on Men Only^*

Patients Using Brand-Name Drug	Oral Hypoglycemics, %	Insulin Analogues, %	Statins, %	ACE Inhibitors/ARBs, %
VA original cohort	12.7	27.0	18.2	20.8
VA men only (sensitivity population)	12.7	27.0	18.2	20.7
Medicare original cohort	35.3	75.1	50.7	42.5
Medicare men only (sensitivity population)	36.4	78.0	50.9	37.3

ACE = angiotensin-converting enzyme; ARB = angiotensin-receptor blocker; VA = Veterans Affairs.

^*“Medicare” refers to patients enrolled in fee-for-service Parts A and B and stand-alone Part D. “Statins” denotes 3-hydroxy-3-methyl coenzyme A reductase inhibitors. A total of 656 753 Medicare beneficiaries (61.9%) and 6957 veterans (1.4%) were excluded.